Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.23.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenue
Operating expenses    
Research and development 6,475,668 3,559,515
General and administrative 1,564,586 1,038,428
Total operating expenses 8,040,254 4,597,943
Loss from operations (8,040,254) (4,597,943)
Interest income 215,017 27,367
Net loss $ (7,825,237) $ (4,570,576)
Per share information:    
Net loss per common share, basic and diluted $ (0.61) $ (0.35)
Weighted average common shares outstanding, basic and diluted 12,913,848 12,944,134